These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 3020252)
1. Investigation of 4-(3-hydroxyphenyl)-4-methylpipecolic acid as a conformationally restricted mimic of the tyrosyl residue of leucine-enkephalinamide. Sugg EE; Portoghese PS J Med Chem; 1986 Oct; 29(10):2028-33. PubMed ID: 3020252 [TBL] [Abstract][Full Text] [Related]
2. Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity. Roubini E; Laufer R; Gilon C; Selinger Z; Roques BP; Chorev M J Med Chem; 1991 Aug; 34(8):2430-8. PubMed ID: 1714957 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and analgesic properties of two leucine-enkephalin analogues containing a conformationally restrained N-terminal tyrosine residue. Deeks T; Crooks PA; Waigh RD J Med Chem; 1983 May; 26(5):762-5. PubMed ID: 6842517 [TBL] [Abstract][Full Text] [Related]
6. delta EPhe4-enkephalin analogs. Delta receptors in rat brain are different from those in mouse vas deferens. Shimohigashi Y; Costa T; Pfeiffer A; Herz A; Kimura H; Stammer CH FEBS Lett; 1987 Sep; 222(1):71-4. PubMed ID: 2820799 [TBL] [Abstract][Full Text] [Related]
7. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13). Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers. Schiller PW; Nguyen TM; Lemieux C; Maziak LA J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological characterization in vitro of cyclic enkephalin analogues: effect of conformational constraints on opiate receptor selectivity. DiMaio J; Nguyen TM; Lemieux C; Schiller PW J Med Chem; 1982 Dec; 25(12):1432-8. PubMed ID: 6296388 [TBL] [Abstract][Full Text] [Related]
10. [Leu5]enkephalin containing peptides derived from a common precursor: evaluation of opioid activity in in vitro bioassays. Sanchez-Blazquez P; Garzon J; Lee NM Eur J Pharmacol; 1984 Mar; 98(3-4):389-96. PubMed ID: 6327333 [TBL] [Abstract][Full Text] [Related]
12. A cyclic enkephalin analog with high in vitro opiate activity. DiMaio J; Schiller PW Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7162-6. PubMed ID: 6261242 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of melphalan-containing N,N-dialkylenkephalin analogues as irreversible antagonists of the delta opioid receptor. Lovett JA; Portoghese PS J Med Chem; 1987 Sep; 30(9):1668-74. PubMed ID: 3041000 [TBL] [Abstract][Full Text] [Related]
14. Effects of structurally different (Leu5) enkephalinamides on electrically-evoked contractions of guinea pig ileum. Radomirov R; Petkov VD; Venkova K Biomed Biochim Acta; 1987; 46(5):381-5. PubMed ID: 2822036 [TBL] [Abstract][Full Text] [Related]
15. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency. Cox BM; Chavkin C Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144 [No Abstract] [Full Text] [Related]
16. Amino acids and peptides. XXIII. Leu-enkephalin analogs containing a fluorinated amino acid at position 2, 4 or 5. Maeda M; Kawasaki K; Taguchi T; Kobayashi Y; Yamamoto Y; Shimokawa K; Takahashi M; Nakao K; Kaneto H Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1658-62. PubMed ID: 7954917 [TBL] [Abstract][Full Text] [Related]